PCEVAXI Stock Latest News
Private CompaniesEvaxion Refocuses Strategy on AI-Driven Cancer Vaccines1d agoEVAXI
Private CompaniesPreclinical Antigen Validation Advances EVX-B4 Vaccine Program2d agoEVAXI
Private CompaniesEvaxion Biotech to Present AI-Based Autoimmune Programs at PEGS Europe1w agoEVAXI
Private CompaniesEvaxion Biotech Sets 2027 Reporting and AGM Schedule1w agoEVAXI
Private CompaniesEVX-01 Phase 2 Data Add Support for Personalized Cancer Vaccine Program1w agoEVAXI
Private CompaniesEvaxion to Present New Preclinical EVX-04 Data at 2026 ASH Meeting2w agoEVAXI
Private CompaniesEvaxion Biotech Platform Recognized With International Prix Galien Award3w agoEVAXI
Private CompaniesEvaxion Biotech Highlights Phase 2 Three-Year Data for Melanoma Vaccine EVX-013w agoEVAXI
Private CompaniesEvaxion Biotech Highlights Durable Responses in Phase 2 Melanoma Vaccine Trial1M agoEVAXIPrivate CompaniesEvaxion Biotech Showcases AI-Driven Vaccine Platform at Major Industry Conference1M agoEVAXI
Private CompaniesEvaxion Biotech Highlights Progress on mRNA Gonorrhoea Vaccine Candidate1M agoEVAXI
Private CompaniesEvaxion Biotech Highlights AI-Immunology Platform and Pipeline at Investor Summit1M agoEVAXI
Private CompaniesEvaxion Biotech Showcases AI-Designed Cancer Vaccine EVX-01 and Early Phase 2 Data1M agoEVAXI
Private CompaniesEvaxion Biotech Expands AI-Immunology Platform Into Autoimmune Disease R&D2M agoEVAXIPrivate CompaniesEvaxion Biotech Expands AI-Immunology Platform Into Autoimmune Disease Therapies2M agoEVAXI





